HLAG Kit ELISA
-
- Antigène Voir toutes HLAG Kits ELISA
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Reactivité
- Humain
- Méthode de détection
- Colorimetric
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 0.625 ng/mL - 40 ng/mL
- Seuil minimal de détection
- 0.625 ng/mL
- Application
- ELISA
- Fonction
- Human Major Histocompatibility Complex Class I G ELISA Kit is an ELISA Kit against Major Histocompatibility Complex Class I G.
- Type d'échantillon
- Plasma, Serum
- Analytical Method
- Quantitative
- Sensibilité
- 0.375 ng/mL
- Featured
- Discover our best selling HLAG Kit ELISA
- Top Product
- Discover our top product HLAG Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes HLAG Kits ELISA
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Autre désignation
- Major Histocompatibility Complex Class I G (HLAG Produits)
- Synonymes
- MHC-G Kit ELISA, B-F Kit ELISA, B-F-S04 Kit ELISA, B-F-S05 Kit ELISA, B-F-S06 Kit ELISA, B-F-S07 Kit ELISA, B-FI Kit ELISA, B-FIV Kit ELISA, BF2 Kit ELISA, BFa2 Kit ELISA, BFw-03 Kit ELISA, BFw-05 Kit ELISA, BFz-01 Kit ELISA, major histocompatibility complex, class I, G Kit ELISA, MHC BF1 class I Kit ELISA, HLA-G Kit ELISA, BF1 Kit ELISA
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-